Published articles (2021):
1. Aghamohammadzadeh N, Haghi TF, Houshyar J, Najafipour F. Glucose tolerance status in patients with newly diagnosed papillary thyroid carcinoma. Immunopathologia Persa. DOI:10.34172/ipp.2021.xx
2. Abdolalipour S, Mirghafourvand M, Mobasseri M, Mohammad-Alizadeh S, Ostadrahimi A, Dolatkhah N, et al. Assessment of Primary Osteoporosis Status in the Postmenopausal Women of Tabriz and the Effect of Curcumin Nanomicelles, Nigella sativa Oil, and Curcumin Nanomicelles and Nigella sativa Oil Soft Capsules on Cellular-Molecular and Clinical Outcomes: A Study Protocol. International Journal of Women’s Health and Reproduction Sciences. 2021; 9(1): 3-10.
3. Zarezadeh R, Nouri M, Hamdi K, Shaaker M, Mehdizadeh A, Darabia M. Fatty acids of follicular fluid phospholipids and triglycerides display distinct association with IVF outcomes. Reproductive BioMedicine Online. 2021; 42(2): 301-309.
4. Motavalli R, Etemadi J, Soltani-Zangbar MS, Ardalan M-R, Kahroba H, Roshangar L, Nouri M, Aghebati-Maleki L, Khiavi FM, Abediazar S. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy. Cytokine. 2021; 141:155452.
5. Zamani M, Yaghoubi Y, Naimi A, Hassanzadeh A, Pourakbari R, Aghebati-Maleki L, Motavalli R, Aghlmandi A, Mehdizadeh A, Nazari M. Humanized Culture Medium for Clinical-Grade Generation of Erythroid Cells from Umbilical Cord Blood CD34+ Cells. Advanced Pharmaceutical Bulletin. 2021; 11(2).
6. Razmi H, Tarighat-Esfanjani A, Payahoo L, Mobasseri M, Amirpour M, Mirzaei E, Ghoreishi Z. Relationship between the levels of serum fibroblast growth factor 19 and metabolic factors in obese and normal weight subjects with and without type 2 diabetes mellitus: a case-control study. Hormone molecular biology and clinical investigation. 2021.
7. Azizi S, Ebrahimi‐Mameghani M, Mobasseri M, Karamzad N, Mahdavi R. Oxidative stress and nitrate/nitrite (NOx) status following citrulline supplementation in type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial. Journal of Human Nutrition and Dietetics. 2021; 34(1):64-72.
8. Tutunchi H, Naeini F, Ebrahimi‐mameghani M, Mobasseri M, Naghshi S, Ostadrahimi A. The association of the steatosis severity, NAFLD fibrosis score, and FIB‐4 index with atherogenic dyslipidemia in adult patients with NAFLD: A cross‐sectional study. International Journal of Clinical Practice. 2021:e14131.
9. Tutunchi H, Ostadrahimi A, Saghafi‐Asl M, Roshanravan N, Shakeri‐Bavil A, Asghari‐Jafarabadi M, Farrin N, Mobasseri M. Expression of NF‐κB, IL‐6, and IL‐10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD—Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple‐blind randomized controlled clinical trial. Journal of Cellular Physiology. 2021; 236(1):417-26.
10. Karimi A, Naeini F, Azar VA, Hasanzadeh M, Niazkar HR, Tutunchi H. A comprehensive systematic review of the therapeutic effects and mechanisms of action of quercetin in sepsis. Phytomedicine. 2021:153567.
11.Abbaszadeh F, Azizi S, Mobasseri M, Ebrahimi-Mameghani M. The effects of citrulline supplementation on meta-inflammation and insulin sensitivity in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Diabetology & Metabolic Syndrome. 2021 Dec;13(1):1-9.
12.Tajaddini A, Roshanravan N, Mobasseri M, Aeinehchi A, Sefid‐Mooye Azar P, Hadi A, Ostadrahimi A. Saffron improves life and sleep quality, glycaemic status, lipid profile and liver function in diabetic patients: A double‐blind, placebo‐controlled, randomised clinical trial. International Journal of Clinical Practice. 2021 May 7:e14334.
13.Azizi S, Mahdavi R, Mobasseri M, Aliasgharzadeh S, Abbaszadeh F, Ebrahimi‐Mameghani M. The impact of L‐citrulline supplementation on glucose homeostasis, lipid profile, and some inflammatory factors in overweight and obese patients with type 2 diabetes: A double‐blind randomized placebo‐controlled trial. Phytotherapy Research. 2021 Jun;35(6):3157-66.
14.Tutunchi H, Mobasseri M, Aghamohammadzadeh N, Hooshyar J, Naeini F, Najafipour F. Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): a case-control study. International journal of clinical practice.:e14555.
15.Tutunchi H, Naeini F, Ebrahimi-Mameghani M, Najafipour F, Mobasseri M, Ostadrahimi A. Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study. Clinics and Research in Hepatology and Gastroenterology. 2021 Jul 22:101754.
16.Nasimidoost Azgomi R, Karimi A, Tutunchi H, Jazani AM. A comprehensive mechanistic and therapeutic insight into the effect of chicory (cichorium intybus) supplementation in diabetes mellitus: A systematic review of literature. International Journal of Clinical Practice. 2021 Oct 4:e14945.
17.Najafipour F, Bahrami A, Niafar M, Houshyar J, Halimi M, Sadra V. Median 10 years follow-up of patients with covert Cushing’s syndrome: a case series. Journal of medical case reports. 2021 Dec;15(1):1-9.
18. Ghavamil M, Houshyar J, Mehdizadeh A, Najafipour M, Najafipour F. Effective Reduction of Inflammatory and Coagulation Factors using Sitagliptin in Type 2 Diabetes. IRANIAN RED CRESCENT MEDICAL JOURNAL. 2021 Mar 1;23(3).
19.Azizi S, Mahdavi R, Mobasseri M, Aliasgharzadeh S, Abbaszadeh F, Ebrahimi‐Mameghani M. The impact of L‐citrulline supplementation on glucose homeostasis, lipid profile, and some inflammatory factors in overweight and obese patients with type 2 diabetes: A double‐blind randomized placebo‐controlled trial. Phytotherapy Research. 2021 Jun;35(6):3157-66.
20.Tutunchi H, Naeini F, Mobasseri M, Ostadrahimi A. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clinical Nutrition ESPEN. 2021 May 7.
21.Hemmati E, Mirghafourvand M, Mobasseri M, Shakouri SK, Mikaeli P, Farshbaf-Khalili A. Prevalence of primary osteoporosis and low bone mass in postmenopausal women and related risk factors. Journal of Education and Health Promotion. 2021;10.
22. Naeini F, Namkhah Z, Tutunchi H, Rezayat SM, Mansouri S, Jazayeri-Tehrani SA, Yaseri M, Hosseinzadeh-Attar MJ. Effects of naringenin supplementation in overweight/obese patients with nonalcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial. Trials. 2021;22(801).
23.Mahmoudi L, Mobasseri M, Ostadrahimi A, Pourmoradian S, Soleimanzadeh H, Kafili B. Effect of selenium-enriched yeast supplementation on serum thyroid-stimulating hormone and anti-thyroid peroxidase antibody levels in subclinical hypothyroidism: Randomized controlled trial. Advanced Biomedical Research. 2021 Jan 1;10(1):33.
24.Naeini F, Namkhah Z, Tutunchi H, Rezayat SM, Mansouri S, Yaseri M, Hosseinzadeh-Attar MJ. Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial. European Journal of Gastroenterology & Hepatology. 2021 Dec 3.
25.Amiri P, Hosseini SA, Ghaffari S, Tutunchi H, Ghaffari S, Mosharkesh E, Asghari S, Roshanravan N. Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review. Frontiers in Pharmacology. 2021;12.
26.Abbasgholizadeh P, Naseri A, Nasiri E, Sadra V. Is Hashimoto thyroiditis associated with increasing risk of thyroid malignancies? A systematic review and meta-analysis. Thyroid research. 2021 Dec;14(1):1-1.
27)Mohammadzadeh A, Roshanravan N, Mesri Alamdari N, Safaiyan A, Mosharkesh E, Hadi A, Barati M, Ostadrahimi A. The interplay between fasting, gut microbiota, and lipid profile. International journal of clinical practice. 2021 Oct;75(10):e14591.